Skip to content
OpenCapital
Get started

The Beauty Health Company SKIN Cash & Equivalents

Cash & Equivalents at other companies

AbbVie logo
AbbVieABBV
$9.39B+81.5%
Solesence, Inc. Common Stock logo
Solesence, Inc. Common StockSLSN
$573K-68.5%
Lifevantage Corporation logo
Lifevantage CorporationLFVN
$12.48M-44.4%
Estee Lauder Companies Inc. logo
Estee Lauder Companies Inc.EL
$3.13B+18.8%
SANUWAVE Health, Inc. logo
SANUWAVE Health, Inc.SNWV
$10.78M+26.8%
NuSkin Enterprises logo
NuSkin EnterprisesNUS
$198.65M-2.5%

Other financials

Income statement

See full
Revenue$64.9M-6.7%
Gross profit$44.4M-8.5%
Operating income-$1.8M+85.0%
Net income-$6.6M+34.3%
EPS (diluted)-$0.05+37.5%

Balance sheet

See full
Total debt$125.9M+756%
Total equity$55.2M+19.9%
Total assets$473.2M-29.8%

Cash flow

See full
Operating cash flow-$5.6M-285%
CapEx$224.0K+398%
Free cash flow-$5.8M-296%

Valuation

See full
Market cap$89.75M-63.3%
Enterprise value$11.24M-97.3%
P/S0.3×-0.5×

Profitability

See full
Gross margin64.9%+8.3pp
Operating margin-3.6%-1.6pp
Net margin-2%-0.9pp
FCF margin9.6%—

Returns & leverage

See full
Return on equity-12%-5.4pp
Debt / equity2.3×+2.0×
Current ratio1.8×-5.7×

Where this comes from

Reported directly by The Beauty Health Company in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: The Beauty Health Company’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about The Beauty Health Company's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is The Beauty Health Company's cash & equivalents?
The Beauty Health Company (SKIN) reported cash & equivalents of $204.36M in Q1 2026.
How has The Beauty Health Company's cash & equivalents changed year-over-year?
The Beauty Health Company's cash & equivalents decreased by 45.2% year-over-year, from $373.03M to $204.36M.
What is the long-term trend for The Beauty Health Company's cash & equivalents?
Over 5 years (2020 to 2025), The Beauty Health Company's cash & equivalents has grown at a 89.6% compound annual growth rate (CAGR), from $9.49M to $232.67M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.